Literature DB >> 21242083

Beyond human rights and public health: citizenship issues in harm reduction.

Jia-shin Chen1.   

Abstract

There have been debates amongst harm reduction practitioners regarding the relationship of universal human rights vis-à-vis public health demands. The ideological debates around these two slippery concepts often obfuscate the important theme of citizenship. The author, therefore, argues for the perspective of citizenship as an alternative to comprehend harm reduction practises more thoroughly. An introduction of the concept of citizenship is followed by a case example of Taiwan's harm reduction policy-making, wherein injection drug users were subjected to various disciplinary actions and made into citizen addicts. It is hoped that more harm reduction researchers will have increased familiarity with the notion of citizenship as a useful tool to examine the power dynamics taking place in the name of harm reduction.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21242083     DOI: 10.1016/j.drugpo.2010.12.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  4 in total

1.  Studying up harm reduction policy: the office as an assemblage.

Authors:  Jia-Shin Chen
Journal:  Int J Drug Policy       Date:  2011-10-13

2.  The impact of Taiwan's implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017.

Authors:  Wei J Chen; Chi-Ya Chen; Shang-Chi Wu; Kevin Chien-Chang Wu; Susyan Jou; Yu-Chi Tung; Tzu-Pin Lu
Journal:  Harm Reduct J       Date:  2021-11-19

3.  Harm reduction policy in Taiwan: toward a comprehensive understanding of its making and effects.

Authors:  Jia-Shin Chen
Journal:  Harm Reduct J       Date:  2016-04-04

4.  Therapy without a prescription: buprenorphine/naloxone diversion and the therapeutic assemblage in Taiwan.

Authors:  Jia-Shin Chen
Journal:  Sociol Health Illn       Date:  2019-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.